September 29, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology industry, presents a compelling case for investors seeking growth opportunities in the healthcare sector. Headquartered in Dublin, Ireland, Jazz..

ICON plc (ICLR) Stock Analysis: An Investor’s Guide to Understanding Its 31.67% Upside Potential

Investors looking for exposure in the healthcare sector, particularly in diagnostics and research, may find ICON plc (NASDAQ: ICLR) an intriguing opportunity. Headquartered in Dublin, Ireland, ICON is a premier..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Landscape with Promising Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) operates at the intersection of healthcare and technology, a sector that continues to attract investor interest due to its transformative potential. Headquartered in New York,..

Akero Therapeutics (AKRO) Stock Analysis: A Promising Biotech with 61.92% Potential Upside

For investors with a keen interest in the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents an intriguing opportunity. Specializing in the development of treatments for serious metabolic diseases, Akero..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Unveiling Potential with a 24.59% Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing attention with its promising portfolio in RNA-targeted therapeutics and gene therapies. As a commercial-stage biopharmaceutical company, Sarepta..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unveiling a 13.58% Potential Upside with Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing significant attention from investors with its strong revenue growth and promising market potential. With a current..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 24% Potential Upside with a Strategic Healthcare Edge

Grifols, S.A. (NASDAQ: GRFS), a prominent name in the healthcare sector and a key player in the global plasma-derived therapies market, is gaining attention from investors due to its promising..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its Valuation and Growth Potential

Avantor, Inc. (NYSE: AVTR) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $8.07 billion, Avantor offers..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotechnology Powerhouse with 41.6% Revenue Growth and Substantial Upside

BeOne Medicines Ltd. (ONC), a Switzerland-based leader in the biotech sector, has been making waves in the oncology space. With its headquarters in Basel, the company focuses on developing innovative..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Masimo Corporation (MASI) Stock Analysis: Evaluating the 32.65% Potential Upside for Investors

Investors seeking opportunities in the healthcare sector’s medical devices industry may find Masimo Corporation (NASDAQ: MASI) a compelling prospect. With a market capitalization of $7.68 billion, Masimo is a notable..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing the Healthcare Giant’s 4.45% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare sector, is capturing investor attention with its robust market presence in diagnostics and research. Based out of Los Angeles, California,..

Legend Biotech Corporation (LEGN) Stock Analysis: Significant Growth Potential with 129.77% Upside

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its innovative approach to oncology treatments. Headquartered in Somerset, New Jersey, Legend Biotech is positioned at the..

Regencell Bioscience Holdings (RGC) Stock Analysis: Uncovering Growth Potential in TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is capturing attention in the healthcare sector for its pioneering work with Traditional Chinese Medicine (TCM). Based in Hong Kong, the company is dedicated..

BioNTech SE (BNTX) Stock Analysis: Unpacking the 38.75% Potential Upside and Analyst Confidence

BioNTech SE (NASDAQ: BNTX) stands as a compelling player in the biotechnology sector, primarily recognized for its groundbreaking work in developing immunotherapies for cancer and infectious diseases. Based in Mainz,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Powerhouse with 110% Potential Upside

Investors on the lookout for promising opportunities in the biotechnology sector should take a closer look at Telix Pharmaceuticals Limited (ASX: TLX), a dynamic player in the healthcare industry. With..

Alkermes plc (ALKS) Stock Analysis: Unpacking a 49.54% Potential Upside for Investors

Alkermes plc (NASDAQ: ALKS), a noteworthy player in the healthcare sector, stands out as a promising investment opportunity with a potential upside of 49.54%. With its robust portfolio addressing critical..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 44% Potential Upside with Robust Revenue Growth

Investors seeking opportunities in the healthcare sector might find Globus Medical, Inc. (NYSE: GMED) an intriguing prospect. This U.S.-based medical device company, with a market cap of $7.52 billion, specializes..

Waters Corporation (WAT)

⚠️ No article content returned.

..
Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds